Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
Background Vitiligo is a chronic autoimmune disease in which the destruction of melanocytes causes white spots on the affected skin. Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-signal transducer and activator of...
Saved in:
Main Authors: | Asmaa Gaber Abdou (Author), Alaa Maraee (Author), Hossam Yassien (Author), Mona Sarhan (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Vishal R. Tandon, et al.
Published: (2022) -
Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo
by: Samaka RM, et al.
Published: (2019) -
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
by: Robert Roskoski, Jr
Published: (2022) -
Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020) -
Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
by: Sineida Berbert Ferreira, et al.
Published: (2021)